Neuroleptics as a guideline to biological research in psychotic disorders

Andén, 1964, Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum, Life Sci, 3, 149, 10.1016/0024-3205(64)90196-1 Andén, 1967, Evidence for dopamine receptor stimulation by apomorphine, J Pharm Pharmacol, 19, 627, 10.1111/j.2042-7158.1967.tb09604.x Andén, 1970, Evidence for a central noradrenaline receptor stimulation by clonidine, Life Sci, 9, 513, 10.1016/0024-3205(70)90207-9 Andén, 1970, Receptor activity and turnover of dopamine and noradrenaline after neuroleptics, Eur J Pharmacol, 11, 303, 10.1016/0014-2999(70)90006-3 Andén, 1971, Influences of cholinergic mechanisms on the function and turnover of brain dopamine, J Pharm Pharmacol, 23, 460, 10.1111/j.2042-7158.1971.tb08686.x Andén, 1972, Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine-β-hydroxylase inhibitors, J Pharm Pharmacol, 24, 177, 10.1111/j.2042-7158.1972.tb08961.x Andén, 1972, Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and antiacethylcholine drugs, J Pharm Pharmacol, 24, 905, 10.1111/j.2042-7158.1972.tb08912.x Angrist, 1971, The comparative psychotomimetic effects of stereo-isomers of amphetamine, Nature, 234, 152, 10.1038/234152a0 Angrist, 1973, Behavioral effects of L-DOPA in schizophrenic patients, Psychopharmacologia, 31, 1, 10.1007/BF00429294 Ayhan, 1973, Behavioral and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines, Psychopharmacologia, 29, 317, 10.1007/BF00429279 Bartholini, 1972, Drugs affecting monoamines in the basal ganglia Bein, 1956, The pharmacology of Rauwolfia, Pharmacol Rev, 8, 435 Bowers, 1969, Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients, Int J Neuropharmacol, 8, 255, 10.1016/0028-3908(69)90046-X Bowers, 1972, Acute psychosis induced by psychotomimetic drug abuse. II. Neurochemical findings, Arch Gen Psychiatry, 27, 440, 10.1001/archpsyc.1972.01750280010002 Bowers, 1973, 5-Hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines, Psychopharmacologia, 28, 309, 10.1007/BF00422751 Carlsson, 1963, Effect of chloropromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain, Acta Pharmacol (Kbh), 20, 140, 10.1111/j.1600-0773.1963.tb01730.x Carlsson, 1972, Potentiation of phenothiazines by a-methyltyrosine in treatment of chronic schizophrenia, J Neural Trans, 33, 83, 10.1007/BF01260898 Chase, 1972, Drug-induced extrapyramidal disorders Chouinard, 1973, Potentation of haloperidol by α-methyldopa in the treatment of schizophrenic patients, Curr Ther Res, 15, 473 Cools, 1973, The caudate nucleus and neurochemical control of behaviour. The function of dopamine and serotonine in the caput nuclei caudati of cats, thesis Ellinwood, 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am J Psychiatry, 130, 1088, 10.1176/ajp.130.10.1088 Friedhoff, 1962, Isolation and characterization of a compound from the urine of schizophrenics, Nature, 194, 897, 10.1038/194897b0 Fuxe, 1970, Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration Goodwin, 1971, Psychiatric side effects of L-DOPA in man, JAMA, 218, 1915, 10.1001/jama.218.13.1915 Goodwin, 1971, Levodopa: Alterations in behavior, Clin Pharmacol Ther, 12, 383, 10.1002/cpt1971122part2383 Hassler, 1970, Unterschiedliche Entleerung der Speicheorte für Noradrenalin, Dopamin und Serotonin als Wirkungsprinzip des Oxypertins, Nervenartz, 41, 105 Hornykiewicz, 1966, Dopamine (3-hydroxytyramine) and brain function, Pharmacol Rev, 18, 925 Hornykiewicz, 1972, Dopamine and extrapyramidal motor function and dysfunction Korf, 1971, Amine metabolism in the human brain: Evaluation of the probenecid test, thesis Lakke, 1973, Clinical significance of the probenecid test, Lancet, 1, 614, 10.1016/S0140-6736(73)90770-8 Mayer-Gross, 1960 Nybäck, 1970, Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues, Eur J Pharmacol, 10, 193, 10.1016/0014-2999(70)90273-6 O'Keeffe, 1970, Effect of drugs used in psychoses on cerebral dopamine metabolism, Br J Pharmacol, 38, 287, 10.1111/j.1476-5381.1970.tb08517.x van Praag, 1967, The possible significance of cerebral dopamine for neurology and psychiatry, Psychiatr Neurol Neurochir, 70, 361 van Praag, 1971, New developments in the field of antidepressants, Comm Contemp Psychiat, 1, 63 van Praag, 1972, Biological psychiatry in perspective. The dangers of sectarianism in psychiatry, Compr Psychiatry, 13, 401, 10.1016/0010-440X(72)90081-8 van Praag HM, Korf J. The influence of neuroleptics on the metabolism of catecholamines in the human brain. Am J Psychiatry (in press) van Praag HM: Towards a biochemical typology of depression? Pharmakopsychiat (in press) Randrup, 1966, Role of catecholamines in the amphetamine excitatory response, Nature, 211, 540, 10.1038/211540a0 Randrup, 1966, Diethyldithiocarbonate and amphetamine stereotype behavior, J Pharm Pharmacol, 18, 752, 10.1111/j.2042-7158.1966.tb07799.x Randrup, 1970, Biochemical, anatomical and psychological investigations of stereotyped behaviour induced by amphetamines Rech, 1966, Alterations in behavior and brain catecholamine levels in rats treated with α-methyltyrosine, J Pharmacol Exp Ther, 153, 412 Richardson, 1973, Depletion of brain norepinephrine by intraventricular injection of 6-hydroxydopa: A biochemical, histochemical and behavioral study in rats, Brain Res, 58, 117, 10.1016/0006-8993(73)90827-5 Rimon, 1971, The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia, J Psychosom Res, 15, 375, 10.1016/0022-3999(71)90051-1 van Rossum, 1967, The significance of dopamine receptor blockade for the action of neuroleptic drugs Sathanathan, 1973, Response threshold to L-DOPA in psychiatric patients, Biol Psychiatr, 7, 139 Segal, 1970, Behavioural activation of rats during intraventricular infusion of norepinephrine, 66, 289 Snyder, 1970, The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs, Am J Psychiatry, 127, 199, 10.1176/ajp.127.2.199 Snyder, 1972, Catecholamines in the brain as mediators of amphetamine psychosis, Arch Gen Psychiatry, 27, 169, 10.1001/archpsyc.1972.01750260021004 Sourkes, 1966, Neurochemical bases of tremor and other disorders of movement, Can Med Assoc J, 94, 53 Southgate, 1971, Some 5-hydroxytryptamine-like actions of fenfluramine: A comparison with (+)-amphetamine and diethylpropion, J Pharm Pharmacol, 23, 600, 10.1111/j.2042-7158.1971.tb08724.x Svensson, 1970, On the role of brain catecholamines in motor activity: Experiments with inhibitors of synthesis and monoamine oxydase, Psychopharmacologia, 18, 357, 10.1007/BF00402762 Thoenen, 1973, The pharmacology of 6-hydroxydopamine, Ann Rev Pharmacol, 13, 169, 10.1146/annurev.pa.13.040173.001125 Woodruff, 1971, Dopamine receptors: A review, Comp Gen Pharmacol, 2, 439, 10.1016/0010-4035(71)90041-3 Yaryura-Tobias, 1970, Action of L-DOPA in drug induced extrapyramidalism, Dis Nerv Syst, 31, 60 Yaryura-Tobias, 1970, The action of L-DOPA on schizophrenic patients (a preliminary report), Curr Ther Res, 12, 528